🏆 NorCemic named Most Innovative Non-Invasive Blood Monitoring Technology Company 2026 | Global Health & Pharma Awards Learn More ›
Pre-Order Now

Accessibility

Display
Dark Mode
High Contrast
Text Size
Font Size
Motion
Reduce Motion

About NorCemic

Pioneering the future of non-invasive health monitoring through quantum-enhanced technology and unwavering commitment to accessibility.

114+
Biomarkers Tracked
<2s
Analysis Time
99.7%
Precision Rate
10
Monk Skin Tones
NorCemic Team
Since 2023 Phoenix, Arizona
Our Story

Born from a Vision to Eliminate Painful Testing

NorCemic was founded with a simple but powerful idea: no one should have to endure painful finger pricks or wait days for lab results to understand their health.

Our team of engineers, data scientists, and healthcare professionals came together to develop breakthrough quantum-enhanced sensing technology that makes comprehensive health monitoring accessible, instant, and completely painless.

Non-invasive technology
Clinical-grade accuracy
Works for all skin tones
Real-time results
Our Values

What Drives Us Forward

Our core values guide every decision we make and every product we build.

Patient First

Every feature starts with one question: How does this improve patient outcomes and quality of life?

Innovation

Pushing the boundaries of what's possible with quantum computing and AI to solve complex problems.

Accuracy

Clinical-grade precision is our goal. We are targeting ±5% accuracy aligned with ISO 15197 standards.

Inclusivity

Our devices are calibrated for all skin tones, ensuring accurate results for everyone, everywhere.

Security

Your health data is protected by HIPAA-compliant, SOC 2 certified infrastructure.

Accessibility

We design for everyone | with features supporting visual, motor, and cognitive needs.

Our Team

Meet the People Behind NorCemic

A diverse team of healthcare innovators, quantum computing experts, and passionate engineers united by one mission.

Leadership Team

Ambima Buzhyason

PhD(c), MS, MBAHM

Chief Executive Officer & Chief Technology Officer

Visionary founder leading NorCemic's mission to democratize health monitoring through quantum-enhanced technology.

Eirik Tjonnfjord

MD

Co-Chief Medical Officer, Hematology

Board-certified hematologist ensuring clinical excellence in blood biomarker analysis and diagnostic accuracy.

Ai Phi Thuy Ho

MD

Co-Chief Medical Officer, Cardiology

Board-certified cardiologist overseeing cardiovascular biomarker integration and cardiac health monitoring.

Ursula Nway

MA, MIR, MSHA

Chief Clinical Liaison Officer

Bridging clinical practice and technology, ensuring seamless integration with healthcare providers and systems.

Parrott Macayo

Chief Operating Officer

Driving operational excellence and strategic execution across all company functions and initiatives.

Our Partners

Trusted Partnerships

We collaborate with industry leaders to bring the best technology and healthcare solutions to our customers.

Voltas Medical LLC

Manufacturing Partner

Amazon Web Services

Cloud & Quantum Computing

Indiegogo

Crowdfunding Platform

ISO Compliant Design

Quality Standards

Our Journey

Company Timeline

Key milestones in our mission to revolutionize health monitoring.

2023

Company Founded

NorCemic Inc. established with seed funding to develop non-invasive biomarker monitoring technology.

2024

QESA Technology Breakthrough

Quantum-enhanced spectral analysis technology developed, targeting clinical-grade accuracy.

2025

Indiegogo Campaign Launch

SmartCemic QESA Pro crowdfunding campaign launches on Indiegogo.

2026

FDA Submission

Planned submission for FDA Class II clearance with comprehensive clinical trial data.

2027

Wearables Ecosystem

Planned release of SmartWatch and Smart Ring expanding the SmartCemic product family.

Join Our Mission

We're always looking for talented individuals who share our vision of making health monitoring accessible to everyone.

View Open Positions Contact Us

NorCemic Support

Online

👋 Hi! How can I help you learn about NorCemic?